Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
European Journal of Gastroenterology & Hepatology
|
April 11, 2013
Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis
Nathalie Brunner, Oliver Senn, Thomas Rosemann, et al.
Addiction (Abingdon, England)
|
January 25, 2019
Chronic obstructive pulmonary disease (COPD) among opioid-dependent patients in agonist treatment. A diagnostic study
Thomas Grischott, Luis Falcato, Oliver Senn, et al.
Swiss Medical Weekly
|
July 6, 2023
Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study
Rosario Agosti-Gonzalez, Luis Falcato, Thomas Grischott, et al.
Sozial- Und Praventivmedizin
|
September 11, 2004
[Is methadone maintenance provided by private practitioners effective?]
Rudolf Stohler, Carlos Nordt, Luis Falcato, et al.
Swiss Medical Weekly
|
January 12, 2022
High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study
Philip Bruggmann, Oliver Senn, Anja Frei, et al.
Sozial- Und Praventivmedizin
|
June 8, 2002
[Psychosocial characteristics, methadone dose and heroin use in ambulatory methadone treatment: a matched-pair design]
Franziska Liechti, Luis Falcato, Kenneth M Dürsteler-Mac Farland, et al.
Addiction (Abingdon, England)
|
April 22, 2024
Prolonged diacetylmorphine take-home during the COVID-19 pandemic-Results of a retrospective cohort study
Franciska Brezan, Maximilian Meyer, Marc Vogel, et al.
BMC Public Health
|
January 8, 2014
Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?
Axel J Schmidt, Luis Falcato, Benedikt Zahno, et al.
Addiction Science & Clinical Practice
|
March 11, 2023
Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study
Jean N Westenberg, Maximilian Meyer, Johannes Strasser, et al.
European Addiction Research
|
July 26, 2021
Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series
Marc Vogel, Patrick Köck, Johannes Strasser, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
European Journal of Gastroenterology & Hepatology
|
April 11, 2013
Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis
Nathalie Brunner, Oliver Senn, Thomas Rosemann, et al.
Addiction (Abingdon, England)
|
January 25, 2019
Chronic obstructive pulmonary disease (COPD) among opioid-dependent patients in agonist treatment. A diagnostic study
Thomas Grischott, Luis Falcato, Oliver Senn, et al.
Swiss Medical Weekly
|
July 6, 2023
Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study
Rosario Agosti-Gonzalez, Luis Falcato, Thomas Grischott, et al.
Sozial- Und Praventivmedizin
|
September 11, 2004
[Is methadone maintenance provided by private practitioners effective?]
Rudolf Stohler, Carlos Nordt, Luis Falcato, et al.
Swiss Medical Weekly
|
January 12, 2022
High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study
Philip Bruggmann, Oliver Senn, Anja Frei, et al.
Sozial- Und Praventivmedizin
|
June 8, 2002
[Psychosocial characteristics, methadone dose and heroin use in ambulatory methadone treatment: a matched-pair design]
Franziska Liechti, Luis Falcato, Kenneth M Dürsteler-Mac Farland, et al.
Addiction (Abingdon, England)
|
April 22, 2024
Prolonged diacetylmorphine take-home during the COVID-19 pandemic-Results of a retrospective cohort study
Franciska Brezan, Maximilian Meyer, Marc Vogel, et al.
BMC Public Health
|
January 8, 2014
Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?
Axel J Schmidt, Luis Falcato, Benedikt Zahno, et al.
Addiction Science & Clinical Practice
|
March 11, 2023
Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study
Jean N Westenberg, Maximilian Meyer, Johannes Strasser, et al.
European Addiction Research
|
July 26, 2021
Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series
Marc Vogel, Patrick Köck, Johannes Strasser, et al.
Page
of 3